Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
1.440
-0.090 (-5.88%)
Nov 4, 2024, 12:54 PM EST - Market open
Taysha Gene Therapies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -114.34 | -111.57 | -166.01 | -174.52 | -60.01 | -4.46 |
| Depreciation & Amortization | 1.34 | 1.37 | 1.17 | 0.49 | 0.01 | - |
| Other Amortization | 0.87 | 0.87 | - | - | - | - |
| Asset Writedown & Restructuring Costs | 1.07 | 4.57 | 37.67 | 9.75 | 9 | 3.92 |
| Stock-Based Compensation | 10.54 | 7.91 | 18.04 | 18.18 | 3.35 | - |
| Other Operating Activities | 41.36 | 41.85 | 2.22 | 0.39 | 17.03 | - |
| Change in Accounts Payable | -2.05 | -2.3 | -7.8 | 14.49 | 1.96 | - |
| Change in Unearned Revenue | -12.87 | -15.45 | 33.56 | - | - | - |
| Change in Other Net Operating Assets | -1.28 | -0.27 | -7.24 | 14.17 | -2.07 | 0.54 |
| Operating Cash Flow | -75.37 | -73.02 | -88.39 | -117.04 | -30.73 | - |
| Capital Expenditures | -0.36 | -3.87 | -20.62 | -15.3 | -0.08 | - |
| Sale (Purchase) of Intangibles | -3.5 | -3.5 | -4.25 | -6.25 | -9 | - |
| Other Investing Activities | 0.02 | 0.02 | -0.06 | - | - | - |
| Investing Cash Flow | -3.84 | -7.35 | -24.93 | -21.55 | -9.08 | - |
| Short-Term Debt Issued | - | - | - | - | 1.67 | - |
| Long-Term Debt Issued | - | 39.55 | - | 39.96 | - | - |
| Total Debt Issued | 39.55 | 39.55 | - | 39.96 | 1.67 | - |
| Short-Term Debt Repaid | - | - | - | - | -1.67 | - |
| Long-Term Debt Repaid | - | -43 | - | - | - | - |
| Total Debt Repaid | -43 | -43 | - | - | -1.67 | - |
| Net Debt Issued (Repaid) | -3.45 | -3.45 | - | 39.96 | - | - |
| Issuance of Common Stock | 210.82 | 140.86 | 53.5 | - | 165.85 | - |
| Other Financing Activities | -0.53 | -1.02 | -1.4 | -0.87 | -0.79 | - |
| Financing Cash Flow | 206.83 | 136.39 | 52.1 | 39.08 | 291.06 | - |
| Net Cash Flow | 127.62 | 56.02 | -61.22 | -99.51 | 251.25 | - |
| Free Cash Flow | -75.73 | -76.89 | -109.01 | -132.35 | -30.81 | - |
| Free Cash Flow Margin | -588.25% | -497.62% | -4356.87% | - | - | - |
| Free Cash Flow Per Share | -0.38 | -0.66 | -2.48 | -3.52 | -1.74 | - |
| Cash Interest Paid | 5.21 | 4.95 | 2.78 | 0.64 | 0.03 | - |
| Levered Free Cash Flow | -53.95 | -68.51 | -75.31 | -71.32 | -32.24 | - |
| Unlevered Free Cash Flow | -53.41 | -66.25 | -72.94 | -70.43 | -32.23 | - |
| Change in Net Working Capital | 13.28 | 23.55 | -11.49 | -40.74 | -0.37 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.